as 12-18-2024 4:00pm EST
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
Founded: | 1971 | Country: | United States |
Employees: | N/A | City: | BURLINGTON |
Market Cap: | 19.2B | IPO Year: | N/A |
Target Price: | $258.29 | AVG Volume (30 days): | 487.4K |
Analyst Decision: | Buy | Number of Analysts: | 16 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 5.14 | EPS Growth: | -31.25 |
52 Week Low/High: | $191.97 - $247.99 | Next Earning Date: | 02-13-2025 |
Revenue: | $12,712,800,000 | Revenue Growth: | 5.43% |
Revenue Growth (this year): | 9.99% | Revenue Growth (next year): | 6.20% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
EISENBERG GLENN A | LH | Executive Vice President | Dec 2 '24 | Sell | $240.43 | 11,711 | $2,815,651.14 | 31,289 | |
Gilliland Dwight Gary | LH | Director | Dec 2 '24 | Sell | $241.00 | 1,000 | $241,000.00 | 7,712 | |
Schechter Adam H | LH | President & CEO | Nov 11 '24 | Sell | $243.47 | 6,189 | $1,506,835.83 | 87,441 | |
ANDERSON KERRII B | LH | Director | Oct 24 '24 | Sell | $230.00 | 1,000 | $230,000.00 | 13,722 |
LH Breaking Stock News: Dive into LH Ticker-Specific Updates for Smart Investing
MT Newswires
a day ago
Zacks
a day ago
PR Newswire
a day ago
MedTech Dive
6 days ago
PR Newswire
22 days ago
Simply Wall St.
23 days ago
PR Newswire
a month ago
Zacks
a month ago
The information presented on this page, "LH Laboratory Corporation of America Holdings - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.